Alzheimer’s Research UK are funding a clinical trial to investigate the use of Sativex®, a cannabis-based medicine for the treatment of behavioral changes experienced as a result of dementia.
Night owls and morning larks have been reported to have fundamental differences in their brain function, according to a new study.
Cannabis use amongst adolescents has been associated with increased risk of depression and anxiety in adulthood, according to a new study.
Researchers have discovered administering pembrolizumab before surgery is more effective for the treatment of recurrent glioblastoma, than when administering the drug afterwards.
According to a recently published survey from Alzheimer’s Research UK, half of UK adults can’t identify a single key risk factor for dementia.
In the largest study of its kind, researchers have identified hundreds of genes newly linked to depression, shedding light on the origins of the condition.
Researchers have identified natural killer cells as a potential therapeutic target for the treatment of neuropathic pain. The immune cells can selectively degenerate axons, allowing repair of damaged nerves.
Couldn’t attend the International Stroke Conference (6–8 February 2019, Honolulu, HI, USA)? Find out more about the key headlines here.
A team of researchers have utilized radiocarbon dating to determine that there is little regeneration of oligodendrocytes in the brains of people living with multiple sclerosis. However, the oligodendrocytes that survive the autoimmune attack can replenish lost myelin.